Terumo has received the actual device for eval; however, the investigation has yet to be completed.Terumo plans on submitted a follow up report when the investigation is complete and more info becomes available.For this reason, terumo referenced eval conclusion.(b)(4).
|
This f/u report is submitted to fda in accord with applicable regulations - and as indicated by terumo cardiovascular system in the initial report submitted to the fda on april 14, 2015.Upon evaluation of the device, the complaint was confirmed.Visual inspection confirmed that the sampling manifold was missing.Magnified inspection revealed that there was a scuff mark on the slot in the reservoir lid where the sampling manifold is inserted.This indicates that a sampling manifold was most likely installed on the reservoir during manufacturing.A retention sample was visually inspected, and the sampling manifold was present.A review of the device history record revealed no production related anomalies.All available information has been placed on file in quality management for appropriate tracking, trending and follow up.
|